Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

Similar articles for PubMed (Select 16755843)

1.

MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.

Cyrus T, Abendschein DR, Caruthers SD, Harris TD, Glattauer V, Werkmeister JA, Ramshaw JA, Wickline SA, Lanza GM.

J Cardiovasc Magn Reson. 2006;8(3):535-41.

PMID:
16755843
2.

Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.

Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM.

Cancer Res. 2003 Sep 15;63(18):5838-43.

3.

Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.

Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, Schmieder AH, Hu G, Allen JS, Lacy EK, Zhang H, Wickline SA, Lanza GM.

Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2103-9. Epub 2006 Jul 6.

4.

Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.

Cyrus T, Zhang H, Allen JS, Williams TA, Hu G, Caruthers SD, Wickline SA, Lanza GM.

Arterioscler Thromb Vasc Biol. 2008 May;28(5):820-6. doi: 10.1161/ATVBAHA.107.156281. Epub 2008 Feb 21.

5.

Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound.

Lanza GM, Abendschein DR, Hall CS, Marsh JN, Scott MJ, Scherrer DE, Wickline SA.

Invest Radiol. 2000 Apr;35(4):227-34.

PMID:
10764091
6.

MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model.

Boles KS, Schmieder AH, Koch AW, Carano RA, Wu Y, Caruthers SD, Tong RK, Stawicki S, Hu G, Scott MJ, Zhang H, Reynolds BA, Wickline SA, Lanza GM.

FASEB J. 2010 Nov;24(11):4262-70. doi: 10.1096/fj.10-157933. Epub 2010 Jun 28.

7.

In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles.

Lanza GM, Abendschein DR, Hall CS, Scott MJ, Scherrer DE, Houseman A, Miller JG, Wickline SA.

J Am Soc Echocardiogr. 2000 Jun;13(6):608-14.

PMID:
10849515
8.

Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.

Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM.

Magn Reson Med. 2005 Mar;53(3):621-7.

PMID:
15723405
9.

Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.

Ala-Korpela M, Sipola P, Kaski K.

Ann Med. 2006;38(5):322-36. Review. Erratum in: Ann Med. 2006;38(7):528.

PMID:
16938802
10.

Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.

Burtea C, Laurent S, Murariu O, Rattat D, Toubeau G, Verbruggen A, Vansthertem D, Vander Elst L, Muller RN.

Cardiovasc Res. 2008 Apr 1;78(1):148-57. doi: 10.1093/cvr/cvm115. Epub 2008 Jan 3.

11.
12.

The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.

Borrirukwanit K, Lafleur MA, Mercuri FA, Blick T, Price JT, Fridman R, Pereira JJ, Leardkamonkarn V, Thompson EW.

Matrix Biol. 2007 May;26(4):291-305. Epub 2006 Nov 7.

PMID:
17175151
13.

Characterization of early neovascular response to acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging.

Schmieder AH, Wang K, Zhang H, Senpan A, Pan D, Keupp J, Caruthers SD, Wickline SA, Shen B, Wagner EM, Lanza GM.

Angiogenesis. 2014 Jan;17(1):51-60. doi: 10.1007/s10456-013-9377-2. Epub 2013 Aug 6.

14.

Accelerated time-resolved 3D contrast-enhanced MR angiography at 3T: clinical experience in 31 patients.

Frydrychowicz A, Bley TA, Winterer JT, Harloff A, Langer M, Hennig J, Markl M.

MAGMA. 2006 Sep;19(4):187-95. Epub 2006 Aug 26.

PMID:
16937136
16.

Activated alphavbeta3 integrin targeting in injury-induced vascular remodeling.

Sadeghi MM, Bender JR.

Trends Cardiovasc Med. 2007 Jan;17(1):5-10. Review.

PMID:
17210471
17.

Ligands for mapping alphavbeta3-integrin expression in vivo.

Schottelius M, Laufer B, Kessler H, Wester HJ.

Acc Chem Res. 2009 Jul 21;42(7):969-80. doi: 10.1021/ar800243b.

PMID:
19489579
18.
19.

Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects.

Palmowski M, Huppert J, Ladewig G, Hauff P, Reinhardt M, Mueller MM, Woenne EC, Jenne JW, Maurer M, Kauffmann GW, Semmler W, Kiessling F.

Mol Cancer Ther. 2008 Jan;7(1):101-9. doi: 10.1158/1535-7163.MCT-07-0409.

20.

Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.

Waldeck J, Häger F, Höltke C, Lanckohr C, von Wallbrunn A, Torsello G, Heindel W, Theilmeier G, Schäfers M, Bremer C.

J Nucl Med. 2008 Nov;49(11):1845-51. doi: 10.2967/jnumed.108.052514. Epub 2008 Oct 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk